News | Imaging | July 16, 2015

Substance Abuse Reduces Brain Volume in Women but Not Men

Structural brain MRI reveals decreased gray matter volume, leading to more impulsive behavior

MRI, substance abuse, women, brain volume, Jody Tanabe, Colorado Denver

July 16, 2015 - Stimulant drug abuse has long-term effects on brain volume in women, according to a new study published online in the journal Radiology. Brain structures involved in reward, learning and executive control showed vast changes even after a prolonged period of abstinence from drug use.

"We found that after an average of 13.5 months of abstinence, women who were previously dependent on stimulants had significantly less gray matter volume in several brain areas compared to healthy women," said the study's senior author, Jody Tanabe, M.D., professor of radiology, vice chair of research, and neuroradiology section chief at the University of Colorado Denver School of Medicine. "These brain areas are important for decision-making, emotion, reward processing and habit formation."

For the study, Tanabe and colleagues sought to determine how the brains of people previously dependent on stimulants differed from the brains of healthy people. "We specifically wanted to determine how these brain effects differed by gender," Tanabe said.

The researchers analyzed structural brain magnetic resonance imaging (MRI) exams in 127 men and women, including 59 people (28 women and 31 men) who were previously dependent on cocaine, amphetamines, and/or methamphetamine for an average of 15.7 years, and 68 healthy people (28 women and 40 men) who were similar in age and gender. The MRI results showed that after an average of 13.5 months of abstinence, women who were previously dependent on stimulants had significantly less gray matter volume in frontal, limbic and temporal regions of the brain.

"While the women previously dependent on stimulants demonstrated widespread brain differences when compared to their healthy control counterparts, the men demonstrated no significant brain differences," Tanabe said.

The researchers also looked at how these brain volume differences were related to behaviors. They found that lower regional gray matter volumes correlated with behavioral tendencies to seek reward and novelty.

"Lower gray matter volumes in women who had been stimulant dependent were associated with more impulsivity, greater behavioral approach to reward and also more severe drug use," Tanabe said. "In contrast, all men and healthy women did not show such correlations."

According to Tanabe, the results may provide a clue to the biological processes underlying the clinical course of stimulant abuse in men and women.

"Compared to men, women tend to begin cocaine or amphetamine use at an earlier age, show accelerated escalation of drug use, report more difficulty quitting and, upon seeking treatment, report using larger quantities of these drugs," she said. "We hope that our findings will lead to further investigation into gender differences in substance dependence and, thus, more effective treatments."

The study first author was Michael Regner, M.D., a radiology resident and Ph.D. graduate student. 

For more information: www.ucdenver.edu

Related Content

Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Siemens Healthineers to Showcase Magentom Vida MRI at RSNA 2017
Technology | Magnetic Resonance Imaging (MRI) | September 18, 2017
September 18, 2017 — Siemens Healthineers announced it will display the new Magnetom Vida 3T...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents
News | Contrast Media | September 12, 2017
The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) voted overwhelmingly...
News | Imaging | September 11, 2017
September 11, 2017 — Innovatus Imaging Corp., a newly created holding company formed by private equity firm Resilienc
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Sponsored Content | Videos | Radiation Therapy | September 08, 2017
The new Visicoil MR is a helically-wound, flexible linear fiducial marker.
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Overlay Init